NYSE:KAPA | Free Cash Flow | Kairos Pharma, LTD.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.04M
2025-12-31-$1.08M
2025-03-31-$714,000.00
2024-12-31-$1.8M
2024-03-31$36,000.00
2023-12-31$66,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$3.44M
2024-12-31-$3.96M
2023-12-31$81,000.00